FTC And FDA Send Cease & Desist Letters To Edible Companies Over Kid-Appealing Products

FK
Frankfurt Kurnit Klein & Selz

Contributor

Frankfurt Kurnit provides high quality legal services to clients in many industries and disciplines worldwide. With leading practices in entertainment, advertising, IP, technology, litigation, corporate, estate planning, charitable organizations, professional responsibility and other areas — Frankfurt Kurnit helps clients face challenging legal issues and meet their goals with efficient solutions.
Yesterday, the FTC announced that, together with the FDA, the agency sent cease and desist letters to companies (Delta Munchies LLC, Exclusive Hemp Farms, Etienne-DuBois, LLC/Oshipt, Hemp Exchange...
United States Cannabis & Hemp
To print this article, all you need is to be registered or login on Mondaq.com.

Yesterday, the FTC announced that, together with the FDA, the agency sent cease and desist letters to companies (Delta Munchies LLC, Exclusive Hemp Farms, Etienne-DuBois, LLC/Oshipt, Hemp Exchange, LLC, dba NC Hemp Shoppe, Dr. Smoke, LLC, aka Dr. S, LLC, Nikte's Wholesale, LLC, and The Haunted Vapor Room) that currently market edibles containing THC in packaging and labeling that the agencies' allege is concerningly appealing to children.

The announcement and letters highlight that many of the companies' products are sold in packaging that "mimic[s] well-known snack food brands by using similar brand names, logos, or pictures on packaging, and that consumers may confuse with traditional foods." Specifically, the agencies' emphasize that some of the products are "almost identical to many snacks and candy children eat, including Doritos tortilla chips, Cheetos cheese-flavored snacks, and Nerds candy" and more.

The letters assert that the companies may be in violation of Section 5 of the FTC Act because their marketing and advertising may present unwarranted health or safety risks, noting that imitating non-THC-containing food products that children consume is a practice the FTC considers misleading.

In addition to the FTC Act allegations, the letters also cite FDA-based concerns for THC-containing products, including that they "have not been evaluated or approved by FDA for safe use and may be marketed in ways that put the public health at risk," among other concerns.

1339792a.jpg

1339792b.jpg

1339792c.jpg

1339792d.jpg

www.fkks.com

This alert provides general coverage of its subject area. We provide it with the understanding that Frankfurt Kurnit Klein & Selz is not engaged herein in rendering legal advice, and shall not be liable for any damages resulting from any error, inaccuracy, or omission. Our attorneys practice law only in jurisdictions in which they are properly authorized to do so. We do not seek to represent clients in other jurisdictions.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More